Baidu
map

全新发现:22种癌症属于遗传疾病!

2016-10-08 佚名 转化医学网

哈佛大学科学家与丹麦和芬兰研究员合作进行的研究发现,至少有22种癌症属于遗传疾病,会在家族之间世代相传。根据这项大型研究的结果,大约三分之一的癌症是遗传的。家族遗传风险最高的包括前列腺癌、乳腺癌、肺癌和肠癌。 哈佛大学科学家与丹麦和芬兰研究员合作进行的研究发现,至少有22种癌症属于遗传疾病,会在家族之间世代相传。 根据这项大型研究的结果,大约三分之一的癌症是遗传



哈佛大学科学家与丹麦和芬兰研究员合作进行的研究发现,至少有22种癌症属于遗传疾病,会在家族之间世代相传。根据这项大型研究的结果,大约三分之一的癌症是遗传的。家族遗传风险最高的包括前列腺癌、乳腺癌、肺癌和肠癌。

哈佛大学科学家与丹麦和芬兰研究员合作进行的研究发现,至少有22种癌症属于遗传疾病,会在家族之间世代相传。

根据这项大型研究的结果,大约三分之一的癌症是遗传的。家族遗传风险最高的包括前列腺癌、乳癌、肺癌和肠癌。科学家发现,如有同胞手足得这些癌症,其他兄弟姊妹得同样癌症的风险会提高33%。这是有史以来规模最大的历时最长的研究遗传与癌症之间关系的研究。研究发现不同的癌症, 遗传风险也不同。其中黑色素瘤和睾丸癌与遗传的关系最为密切。

总体的研究结果并不令人惊讶,而是进一步证实了早先的研究结果,即约1/3的癌症病例是由于基因缺陷引起的,其余的大多数归咎于所谓的生活方式因素,如吸烟、饮食和运动。

不同类型的癌症,遗传风险不同

由哈佛公共卫生学院Lorelei Mucci领导的研究小组在美国医学协会杂志上报道,目前发现约38%的肾脏癌、31%的乳腺癌、27%的子宫癌、58%的黑色素瘤、57%的前列腺癌和39%的卵巢癌与遗传有关。

研究人员表示,超过8%的儿童癌症患者家族中存在意料之外的的基因突变。这些突变不仅使孩子们在未来存在癌症的风险,也可能意味着他们的父母、兄弟姐妹也有一个非常高的患癌风险。Jude儿童研究医院的孟菲斯认为,研究结果不仅用新的方法来检测孩子和他们的家属存在的癌症风险,也可能会找到更好的方法来治疗他们。

这项研究从1943到2010年,对瑞典、挪威、丹麦和芬兰的20多万对双胞胎进行追踪调查,对每个人平均追踪32年。这种大规模双胞胎研究,使科学家得以评估遗传因素对癌症的重要性,并借着衡量同卵和异卵双胞胎的基因异同,评估家族罹癌风险。同卵双胞胎的基因是完全相同的,而异卵双胞胎的基因只是相似,所以这两者中患癌风险的差异明确指向为遗传因素。

Mucci的研究小组还发现,有38%的同卵双胞胎和26%的异卵双胞胎被诊断为癌症。当双胞胎中的其中一人确诊患癌后,另一人患癌的风险会显着增加,异卵双胞胎的风险为37%,而同卵双胞胎的风险则高达46%。南丹麦大学的Jacob Hjelmborg说:“由于本次研究规模庞大,跟踪时间长,我们可以看到关键基因对多种类型癌症的影响。”

睾丸癌的遗传风险很高。如果一个人的异卵双胞胎兄弟患有睾丸癌,那么他患睾丸癌的风险会增加12倍。而对同卵双胞胎来说,一人患睾丸癌,另一人患睾丸癌的风险则会增加28倍。

调查小组还发现:大约1%的人得到了黑色素瘤,这是皮肤癌的最致命的形式。如果异卵双胞胎中一人患有黑色素瘤,另一人患黑色素瘤的风险为6%,而对同卵双胞胎来说,另一人患黑色素瘤的风险为20%。

患前列腺癌和乳腺癌的风险可能是由于他们小时候共处在一个子宫内,两者都强烈地受到激素的影响,包括那些影响胎儿生长的激素。肺癌受环境影响较大,可能是由于双胞胎的吸烟习惯大多相同。

需要注意的是,在参加了该项研究的北欧国家中,癌症是引起死亡的第一大原因。在美国及其他发达国家中,癌症是引起死亡的第二大原因,仅次于心脏病。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1921140, encodeId=a8751921140d7, content=<a href='/topic/show?id=6bfa58133ef' target=_blank style='color:#2F92EE;'>#新发现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58133, encryptionId=6bfa58133ef, topicName=新发现)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=644e456, createdName=vera_1203, createdTime=Fri Jun 09 11:05:00 CST 2017, time=2017-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1667071, encodeId=04be166e07101, content=<a href='/topic/show?id=93d7951895b' target=_blank style='color:#2F92EE;'>#遗传疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95189, encryptionId=93d7951895b, topicName=遗传疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8bd226091152, createdName=lvliquan, createdTime=Fri Dec 16 11:05:00 CST 2016, time=2016-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=142276, encodeId=16761422e6b8, content=继续关注!, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Sun Oct 09 00:24:22 CST 2016, time=2016-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=142275, encodeId=21011422e594, content=谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Sun Oct 09 00:24:15 CST 2016, time=2016-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=142252, encodeId=9aa714225298, content=有原文吗?, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150902/IMG55E708CF2A1056150.jpg, createdBy=58951647724, createdName=sunshw0802, createdTime=Sun Oct 09 00:15:14 CST 2016, time=2016-10-09, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1921140, encodeId=a8751921140d7, content=<a href='/topic/show?id=6bfa58133ef' target=_blank style='color:#2F92EE;'>#新发现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58133, encryptionId=6bfa58133ef, topicName=新发现)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=644e456, createdName=vera_1203, createdTime=Fri Jun 09 11:05:00 CST 2017, time=2017-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1667071, encodeId=04be166e07101, content=<a href='/topic/show?id=93d7951895b' target=_blank style='color:#2F92EE;'>#遗传疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95189, encryptionId=93d7951895b, topicName=遗传疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8bd226091152, createdName=lvliquan, createdTime=Fri Dec 16 11:05:00 CST 2016, time=2016-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=142276, encodeId=16761422e6b8, content=继续关注!, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Sun Oct 09 00:24:22 CST 2016, time=2016-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=142275, encodeId=21011422e594, content=谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Sun Oct 09 00:24:15 CST 2016, time=2016-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=142252, encodeId=9aa714225298, content=有原文吗?, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150902/IMG55E708CF2A1056150.jpg, createdBy=58951647724, createdName=sunshw0802, createdTime=Sun Oct 09 00:15:14 CST 2016, time=2016-10-09, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1921140, encodeId=a8751921140d7, content=<a href='/topic/show?id=6bfa58133ef' target=_blank style='color:#2F92EE;'>#新发现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58133, encryptionId=6bfa58133ef, topicName=新发现)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=644e456, createdName=vera_1203, createdTime=Fri Jun 09 11:05:00 CST 2017, time=2017-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1667071, encodeId=04be166e07101, content=<a href='/topic/show?id=93d7951895b' target=_blank style='color:#2F92EE;'>#遗传疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95189, encryptionId=93d7951895b, topicName=遗传疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8bd226091152, createdName=lvliquan, createdTime=Fri Dec 16 11:05:00 CST 2016, time=2016-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=142276, encodeId=16761422e6b8, content=继续关注!, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Sun Oct 09 00:24:22 CST 2016, time=2016-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=142275, encodeId=21011422e594, content=谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Sun Oct 09 00:24:15 CST 2016, time=2016-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=142252, encodeId=9aa714225298, content=有原文吗?, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150902/IMG55E708CF2A1056150.jpg, createdBy=58951647724, createdName=sunshw0802, createdTime=Sun Oct 09 00:15:14 CST 2016, time=2016-10-09, status=1, ipAttribution=)]
    2016-10-09 知难而进

    继续关注!

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1921140, encodeId=a8751921140d7, content=<a href='/topic/show?id=6bfa58133ef' target=_blank style='color:#2F92EE;'>#新发现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58133, encryptionId=6bfa58133ef, topicName=新发现)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=644e456, createdName=vera_1203, createdTime=Fri Jun 09 11:05:00 CST 2017, time=2017-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1667071, encodeId=04be166e07101, content=<a href='/topic/show?id=93d7951895b' target=_blank style='color:#2F92EE;'>#遗传疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95189, encryptionId=93d7951895b, topicName=遗传疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8bd226091152, createdName=lvliquan, createdTime=Fri Dec 16 11:05:00 CST 2016, time=2016-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=142276, encodeId=16761422e6b8, content=继续关注!, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Sun Oct 09 00:24:22 CST 2016, time=2016-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=142275, encodeId=21011422e594, content=谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Sun Oct 09 00:24:15 CST 2016, time=2016-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=142252, encodeId=9aa714225298, content=有原文吗?, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150902/IMG55E708CF2A1056150.jpg, createdBy=58951647724, createdName=sunshw0802, createdTime=Sun Oct 09 00:15:14 CST 2016, time=2016-10-09, status=1, ipAttribution=)]
    2016-10-09 知难而进

    谢谢分享!

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1921140, encodeId=a8751921140d7, content=<a href='/topic/show?id=6bfa58133ef' target=_blank style='color:#2F92EE;'>#新发现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58133, encryptionId=6bfa58133ef, topicName=新发现)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=644e456, createdName=vera_1203, createdTime=Fri Jun 09 11:05:00 CST 2017, time=2017-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1667071, encodeId=04be166e07101, content=<a href='/topic/show?id=93d7951895b' target=_blank style='color:#2F92EE;'>#遗传疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95189, encryptionId=93d7951895b, topicName=遗传疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8bd226091152, createdName=lvliquan, createdTime=Fri Dec 16 11:05:00 CST 2016, time=2016-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=142276, encodeId=16761422e6b8, content=继续关注!, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Sun Oct 09 00:24:22 CST 2016, time=2016-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=142275, encodeId=21011422e594, content=谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Sun Oct 09 00:24:15 CST 2016, time=2016-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=142252, encodeId=9aa714225298, content=有原文吗?, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150902/IMG55E708CF2A1056150.jpg, createdBy=58951647724, createdName=sunshw0802, createdTime=Sun Oct 09 00:15:14 CST 2016, time=2016-10-09, status=1, ipAttribution=)]
    2016-10-09 sunshw0802

    有原文吗?

    0

相关资讯

ACS Cent Sci:庞贝氏症治疗取得突破

在最新发表于《ACS Central Science》期刊的研究中,纽约大学和荷兰莱顿大学的科学家们在庞贝氏症(Pompe disease)治疗方面取得了重大突破。 庞贝氏症是一种由基因缺陷导致的遗传疾病,患者会缺乏被称为酸性α-葡萄糖苷酶(acid alpha-glucosidase,GAA)的酶,体内肌肉和神经细胞受损,发生进行性肌无力。 在2010年哈里森福特主演电影《良医妙药(E

Nature子刊披露:新生儿筛查给父母带来的却是一场困惑

导语:新生儿筛查给家庭带来了哪些好处?家长如何利用该信息?近日,发表在《 Genetics in Medicine》杂志上的研究揭示,新生儿遗传病携带者筛查会使父母困惑,很多人不知道该如何正确使用该信息。新生儿筛查给家庭带来了哪些好处?家长如何利用该信息?近日,发表在《 Genetics in Medicine》杂志上的研究揭示,新生儿遗传病携带者筛查会使父母困惑,很多人不知道该如何正确使用该信息

Nat Cell Biol:科学家阐明引发常见人类遗传疾病的发病机制

近日,发表于国际杂志Nature Cell Biology上的一篇研究论文中,来自英国利兹大学的研究人员通过研究揭开了参与一系列常见遗传病发病的全面的基因列表,这就意味着,未来多种纤毛疾病(ciliopathies)就可以进行快速诊断,同时也为开发新型疗法提供了一定的思路。 纤毛疾病是由细胞中纤毛、指状样的突出物的缺失而引发,而这些突出物扮演了细胞的“微型天线”来帮助其检测细胞外部的液体流量以及

Baidu
map
Baidu
map
Baidu
map